
Journal of Medicinal Chemistry p. 84 - 89 (1986)
Update date:2022-07-30
Topics:
Lin, Tai-Shun
Wang, Lin
Antonini, Ippolito
Cosby, Lucille A.
Shiba, David A.
et al.
A series of (o-and p-nitrobenzyloxycarbonyl)-5-fluorouracil derivatives were synthesized by reacting o- or p-nitrobenzyl chloroformate with 5-fluorouracil in the presence of triethylamine in DMF or Me2SO.The reductive activation of these agents was hypothesized to generate a reactive methide and 5-fluorouracil, two components that are capable of synergistic interaction through complementary inhibition.Measurement of the surviving fractions of EMT6 tumor cells treated with these agents in culture under conditions of hypoxia and aerobiosis resulted in equal cell kill regardless of the state of oxygenation.One of the synthesized agents, 3-(p-nitrobenzyloxycarbonyl)-5-fluorouracil (4), appeared to be superior to 5-fluorouracil in prolonging the survival time of mice bearing intraperitoneal implants of the P388 leukemia and Sarcoma 180.
View MoreContact:+1-284-4950244
Address:Box 3069, Road Town, Tortola, British Virgin Islands
Contact:+86-21-56338808
Address:799 Dunhuang Road, Putuo
Beijing Harmony Chemical Co., Ltd.
Contact:86-010-84956928
Address:Room 207, Jin feng he B building, No 8 Xin Jie Kou Wai Street, Xi Cheng District, Beijing,PRC. 10008
website:https://www.sinoshiny.com/products
Contact:+86-20-62802632;62802633
Address:Room 330 GIGCAS Building,No.511 Kehua Street,Tianhe District
Synchem Pharma Co.,Ltd(expird)
Contact:+0086-21-61984905-1
Address:Building 60,Zimian Park, LongYang industrial Area, 1515Nong,Yuandong Road Fengxian District, Shanghai ,China
Doi:10.1021/om00131a032
(1985)Doi:10.1016/S0040-4039(00)88555-X
(1990)Doi:10.1016/S0031-9422(00)83736-X
(1986)Doi:10.1021/jm00152a007
(1986)Doi:10.1021/jo00249a013
(1988)Doi:10.1016/S0040-4020(01)88656-7
(1983)